Concurrent activating KIT mutations in systemic mastocytosis

Br J Haematol. 2016 Apr;173(1):153-6. doi: 10.1111/bjh.13560. Epub 2015 Jun 16.
No abstract available

Keywords: KIT D816V; imatinib; mast cell; myeloproliferative; tyrosine kinase inhibitor.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Female
  • Humans
  • Male
  • Mastocytosis, Systemic / genetics*
  • Mutation*
  • Proto-Oncogene Proteins c-kit / genetics*

Substances

  • Proto-Oncogene Proteins c-kit